Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SIRUKUMAB for Prostatic specific antigen: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 47 adverse event reports in the FDA FAERS database where SIRUKUMAB was used for Prostatic specific antigen.

Most Reported Side Effects for SIRUKUMAB

Side Effect Reports % Deaths Hosp.
Off label use 798 59.3% 582 553
Drug ineffective 775 57.6% 385 382
Rheumatoid arthritis 663 49.3% 393 413
Nausea 656 48.8% 394 416
Pain 629 46.8% 422 438
Synovitis 623 46.3% 421 435
General physical health deterioration 619 46.0% 362 379
Rash 565 42.0% 400 416
Pericarditis 562 41.8% 422 424
Pemphigus 561 41.7% 421 420
Drug hypersensitivity 559 41.6% 398 410
Joint swelling 557 41.4% 361 378
Systemic lupus erythematosus 554 41.2% 414 415
Osteoarthritis 539 40.1% 332 283
Wound 530 39.4% 393 392

Other Indications for SIRUKUMAB

Product used for unknown indication (1,090) Rheumatoid arthritis (150) Exposure during pregnancy (28) Foetal exposure during pregnancy (13)

Other Drugs Used for Prostatic specific antigen

GOLIMUMAB (848) SECUKINUMAB (100) ADALIMUMAB (43) METHYLPREDNISOLONE (30) APREMILAST (23) METHOTREXATE (18) CERTOLIZUMAB PEGOL (15) HYDROXYCHLOROQUINE (15) TOFACITINIB (11) ETANERCEPT (9)

Related Pages

SIRUKUMAB Full Profile All Prostatic specific antigen Drugs SIRUKUMAB Demographics SIRUKUMAB Timeline